版本:
中国

BRIEF-TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017

April 3 TherapeuticsMD Inc

* TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017

* TherapeuticsMD Inc - Results of replenish trial show positive safety and efficacy of TX-001HR

* TherapeuticsMD - Trial achieved statistically significant, clinically meaningful reduction in both frequency and severity of hot flashes compared to placebo Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐